MARATTO

article · JAC-Antimicrobial Resistance

Carbapenem and colistin-resistant <i>Klebsiella pneumoniae</i> co-producing NDM-5 and OXA-48 in a teaching hospital from Tunisia

2026Open accessUniversity of Sousse

Abstract

Here we report double carbapenemase producing and colistin-resistant <i>Kp</i>s with limited therapeutic options. Major efforts are needed in infection control and availability of novel molecules in Tunisia to restore safe conditions in hospitals.

Research topics

  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Antimicrobial agents and applications

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1093/jacamr/dlag043

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.